Demand Of Fetal And Neonatal Heart Monitor To Grow At CAGR Of 5.5% By 2032

Worldwide sales of foetal and neonatal cardiac monitors are anticipated to surpass 261,000 units in 2018, with rising US usage driving more sales. Cardiotocographs continue to be the most well-liked newborn and foetus heart monitors, with global sales of little under $400 million in 2017.

The majority of the demand is still met by hospitals and neonatal clinics, with the former continuing to rule.

Download FREE Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=750?pk

The development of foetal and neonatal cardiac monitors is still driven by the desire to lower the incidence of preterm deliveries. According to statistics from the National Center for Health Statistics, the US has one of the highest rates of infant mortality among developed countries. The ratio of deaths per live birth continues to worry European governments and medical professionals.

According to the report, makers of foetal and neonatal cardiac monitors will discover that Asia Pacific excluding Japan (APEJ) would be a lucrative market during the assessment period. There has been a concerted effort by governments and healthcare providers to reduce the high infant mortality rates in many nations in the region.
Due to an increase in NICU admissions, the use of foetal and neonatal heart rate monitoring is also rising. During the assessment period, the market for foetal and neonatal heart monitors is likely to expand due to the expanding applications and implementation of monitoring technology in NICUs. Key market players now have more opportunities as a result of the rise of NICUs.

According to the study, rising preterm birth rates in developing nations like India have caused the creation of new neonatal intensive care units (NICUs), which has opened up prospects for the use of foetal and neonatal heart monitors. Although the market for foetal and neonatal heart monitors has a promising future, performance issues and inaccurate data are still a barrier to expansion. Problems with inaccurate heart rate monitoring can produce inaccurate readings, which in turn can produce ambiguity. Manufacturers are concentrating on releasing innovative and original items in the market in an effort to address these issues. Smart pulse foetal monitoring technology was created by Philips Avalon and uses cross channel verification to ensure accurate data. According to the report, manufacturers will continue to prioritise research.

Request Customized Report as Per Your Requirements: https://www.factmr.com/connectus/sample?flag=RC&rep_id=750?pk

Fetal and Neonatal Heart Monitor Market Taxonomy & Segmentation Analysis

This report also offers a scrutinized study on the market for fetal and neonatal heart monitor in terms of a segmentation analysis.
The market has been divided into five key segments, viz., product type, end-user, modality, and region.

These segments have been analyzed in detail, engulfing market forecasts and estimates at a country and regional level.

The segmentation analysis offered can be useful for the report readers in understanding probable opportunities and potential markets for the target product - fetal and neonatal heart monitor.
A taxonomy table incorporated in the report illustrates all the market segments in a systematic manner as depicted below.
Region
• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA
Product Type
• Cardiotocograph
• Doppler
• Accessories
Modality
• Table Top Devices
• Portable and Hand Held Devices
End-User
• Hospitals
• Neonatal Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers

Get Full Access of Complete Report: https://www.factmr.com/checkout/750

Fetal and Neonatal Heart Monitors that Detect Metabolic Disorders an Opportunity for Market Participants

The report finds that market participants have an opportunity of developing fetal and neonatal heart monitors that can diagnose heart rate patterns occurring due to metabolic disorders, such as fetal metabolic acidemia. The fetal and neonatal heart monitors available in the market are not completely successful in detecting metabolic disorders, with many instances going undetected. Manufacturers who are able to launch highly accurate and advanced fetal and neonatal heart monitors in the market can leverage the opportunities emerging in this segment.

Demand for table top fetal and neonatal heart monitor devices is higher than portable and handheld variants. Hospitals and neonatal clinics around the globe prefer table top devices due to workforce familiarity and cost benefits. The report projects demand for table top devices to be higher than portable and handheld devices over the forecast period.

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.